Historical Perspectives and Treatments in Epilepsy

Epilepsy has been recorded since antiquity under the moniker “the sacred disease”. Early explanations ranged from divine possession and humoral imbalance to lunar influences. In the Greco-Roman era, physicians first proposed a cerebral origin. Through the Middle Ages and Renaissance, treatments were largely empirical, encompassing herbal remedies, bloodletting and exorcism. The 19th century saw the separation of idiopathic and symptomatic forms and the advent of neuropathology alongside the first electroencephalographic observations. The discovery of bromide salts and subsequently phenobarbital heralded modern pharmacotherapy. The late 20th century introduced a multitude of antiseizure drugs targeting GABAergic and glutamatergic systems, improving seizure control and tolerability. Contemporary strategies extend beyond medication to include surgical resection in focal epilepsies, neuromodulation via vagus nerve and deep brain stimulation, and emerging gene-based and optogenetic approaches. This continuum of historical insight underpins the quest for precision treatments and highlights the disorder’s enduring global impact.

Research from Nature Portfolio

Recent studies have applied genome editing to mend monogenic epilepsies, exemplified by targeted correction of sodium-channel gene mutations in rodent models, resulting in marked seizure reduction and improved neurodevelopmental outcomes. Parallel efforts have harnessed optogenetic methods to regulate neural circuits, using light-activated channels to strengthen inhibitory transmission in thalamocortical networks and avert absence seizures. Advances in high-resolution functional imaging combined with electrophysiology have mapped seizure propagation pathways, identifying novel molecular targets and refining candidate sites for neuromodulation.

Historical Perspectives and Treatments in Epilepsy publication trend

The graph below shows the total number of articles in historical perspectives and treatments in epilepsy across all publications each year (not limited to Nature Index journals).

Technical terms

Epileptogenesis: Process by which a normally functioning brain develops epilepsy, often following injury or genetic mutation.

Antiseizure drugs: Medications designed to prevent or reduce the occurrence of epileptic seizures by modulating neurotransmitter systems.

Neuromodulation: Therapeutic interventions that alter neural activity through targeted electrical or magnetic stimulation.

Optogenetics: Technique using light-sensitive proteins to control the activity of specific neurons, enabling precise modulation of neural circuits.

Gene therapy: Delivery of genetic material into cells to correct or compensate for defective genes responsible for disease.

References

1. Could Valerian Have Been the First Anticonvulsant?. Epilepsia (2004).
2. Etiopathogenic theories of nervous system diseases in Vilnius in the early 19th century: “insanity and epilepsy exacerbate when the moonlight shines”. Neurologijos seminarai (2023).
3. Alcmaeon of Croton - Father of Neuroscience? Brain, Mind and Senses in the Alcmaeon’s Study. Neurology and Neuroscience (2017).
4. Epilepsy and Neuroscience: Evolution and Interaction. Frontiers in Neuroanatomy (2020).
5. Second Generation of Antiepileptic Drugs and Oxidative Stress. International Journal of Molecular Sciences (2023).
6. Epilepsy: Mitochondrial connections to the ‘Sacred’ disease. Mitochondrion (2023).
7. Novel Approaches for Treatment of Epilepsy. Pakistan Journal of Health Sciences (2023).